Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Mol Pharmacol. 2010 Feb;77(2):136-8. doi: 10.1124/mol.109.062133. Epub 2009 Nov 10.
T-type calcium channels are important modulators of both membrane potential and intracellular Ca(2+) concentration, allowing them to play key roles in such diverse processes as aldosterone production from adrenal glomerulosa cells to boosting pain signals in nociceptors. In both these examples, the Ca(v)3.2 isoform mediates Ca(2+) influx. This isoform is also of particular interest because mutations in its gene (CACNA1H) that enhance channel activity have been associated with idiopathic generalized epilepsies, whereas mutations that disrupt its activity have been associated with autism spectrum disorders. Block of T-channel activity has been proposed to contribute to the therapeutic usefulness of a wide variety of drugs, such as antihypertensives, antipsychotics, and antidepressants. Recent evidence strongly supports the hypothesis that block of Ca(v)3.2 channels might be useful in the treatment of neuropathic pain. Therefore, it is of particular interest that Ca(v)3.2 channels are exquisitely regulated by G protein-coupled receptors and various downstream effectors. This Perspective summarizes recent findings (p. 202) on this regulation and the novel pathways specifically activated by either neurokinin I, corticotropin-releasing factor receptor 1, or dopamine D(1) receptors.
T 型钙通道是膜电位和细胞内 Ca(2+)浓度的重要调节剂,使它们在各种过程中发挥关键作用,如肾上腺球状带细胞中醛固酮的产生,以及增强伤害感受器中的疼痛信号。在这两个例子中,Ca(v)3.2 同工型介导 Ca(2+)内流。该同工型特别有趣,因为其基因 (CACNA1H) 中的突变增强了通道活性,与特发性全身性癫痫有关,而破坏其活性的突变与自闭症谱系障碍有关。T 型通道活性的阻断被认为有助于多种药物的治疗用途,如抗高血压药、抗精神病药和抗抑郁药。最近的证据强烈支持这样一种假设,即 Ca(v)3.2 通道的阻断可能对治疗神经性疼痛有用。因此,特别有趣的是,G 蛋白偶联受体和各种下游效应物对 Ca(v)3.2 通道进行精细调节。本观点总结了最近关于这种调节的发现(第 202 页),以及神经激肽 I、促肾上腺皮质激素释放因子受体 1 或多巴胺 D(1)受体特异性激活的新途径。